Stay updated on PRTX-100-202 Study in ITP Clinical Trial
Sign up to get notified when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.

Latest updates to the PRTX-100-202 Study in ITP Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 on the site. No study content or page data appear to be altered.SummaryDifference0.1%

- Check40 days agoChange DetectedThe footer shows Revision: v3.4.3 and no longer shows Revision: v3.4.2, indicating a small site version update.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 and does not alter core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now shows revision v3.4.1, replacing the previous v3.4.0; this appears to be a minor update with no visible changes to study details or functionality.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor site version change with no effect on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check112 days agoChange DetectedA new unified 'Locations' section was added, listing study sites in California, Massachusetts, Michigan, New York, Ohio, AB, and Leichester, with the revision updated to v3.3.3. The old location-specific subpages and the 'HHS Vulnerability Disclosure' link were removed, reflecting the updated structure.SummaryDifference0.9%

Stay in the know with updates to PRTX-100-202 Study in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.